As of Feb 03, 2025, CVS Health Corporation Intrinsic Value is $212.7. This suggests it may be undervalued by 280.2% compared to its current price of around $56.0.
As of Feb 03, 2025, CVS Health Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $371.2. This suggests it may be overvalued by 563.4% to its current price of around $56.0, using a discount rate of 3.9% and terminal growth rate of 3.0%.
CVS Health Corporation is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $212.7, compared to a market price of around $56.0. This suggests a potential undervaluation of 280.2%.